OZEM vs. CNCR
OZEM (Roundhill Glp-1 & Weight Loss ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. OZEM is actively managed, while CNCR is passively managed. OZEM charges 0.59%/yr vs 0.79%/yr for CNCR.
Performance
OZEM vs. CNCR - Performance Comparison
Loading charts...
Returns By Period
OZEM
- 1D
- -0.73%
- 1M
- -4.02%
- YTD
- -11.95%
- 6M
- -5.58%
- 1Y
- 21.16%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
OZEM vs. CNCR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
OZEM Roundhill Glp-1 & Weight Loss ETF | -14.07% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
OZEM vs. CNCR - Sectors Allocation Comparison
Sectors
OZEM
CNCR
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
OZEM
CNCR
Financial Services
OZEM
CNCR
Basic Materials
OZEM
-
CNCR
-
Communication Services
OZEM
-
CNCR
-
Consumer Cyclical
OZEM
-
CNCR
-
Consumer Defensive
OZEM
-
CNCR
-
Energy
OZEM
-
CNCR
-
Industrials
OZEM
-
CNCR
-
Real Estate
OZEM
-
CNCR
-
Technology
OZEM
-
CNCR
-
Utilities
OZEM
-
CNCR
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OZEM vs. CNCR — Risk / Return Rank
OZEM
CNCR
OZEM vs. CNCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Roundhill Glp-1 & Weight Loss ETF (OZEM) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OZEM | CNCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.16 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.11 | — | — |
| Martin ratioReturn relative to average drawdown | 2.30 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OZEM | CNCR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.87 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | — | — |
Drawdowns
OZEM vs. CNCR - Drawdown Comparison
The maximum OZEM drawdown since its inception was -28.65%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for OZEM and CNCR.
Loading charts...
Drawdown Indicators
| OZEM | CNCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.65% | 0.00% | -28.65% |
Max Drawdown (1Y)Largest decline over 1 year | -19.16% | — | — |
Current DrawdownCurrent decline from peak | -18.74% | 0.00% | -18.74% |
Average DrawdownAverage peak-to-trough decline | -8.90% | 0.00% | -8.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.22% | — | — |
Volatility
OZEM vs. CNCR - Volatility Comparison
Loading charts...
Volatility by Period
| OZEM | CNCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.67% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 17.15% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 24.46% | 0.00% | +24.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.04% | 0.00% | +25.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.04% | 0.00% | +25.04% |
OZEM vs. CNCR - Expense Ratio Comparison
OZEM has a 0.59% expense ratio, which is lower than CNCR's 0.79% expense ratio.
Dividends
OZEM vs. CNCR - Dividend Comparison
OZEM's dividend yield for the trailing twelve months is around 1.36%, while CNCR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% | 0.00% |
OZEM Roundhill Glp-1 & Weight Loss ETF | 1.36% | 1.20% | 0.22% |
Frequently Asked Questions
On fees, OZEM is cheaper at 0.59% per year. The better choice depends on whether you care most about return, fees, risk, or income.
OZEM is cheaper with a 0.59% expense ratio, compared with 0.79% for CNCR.
OZEM has the higher dividend yield at 1.36%, compared with 0.00% for CNCR.
They also come from different issuers: Roundhill and Exchange Traded Concepts. Their fees differ too: 0.59% for OZEM and 0.79% for CNCR.
Find the right allocation for OZEM and CNCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer